ロード中...
Adjuvant Endocrine Therapy in Premenopausal Patients
Endocrine adjuvant therapy is the best-described molecular targeted treatment and should therefore be used for all patients with endocrine-responsive breast cancer. Ta-moxifen for 5 years is standard of care and has proven efficacy in premenopausal patients. The combination of tamoxifen with ovarian...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger GmbH
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931102/ https://ncbi.nlm.nih.gov/pubmed/20824025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000156985 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|